The dream team reconvened — with one new voice — to answer a bigger question than "how does the app work." Namely: how does it change the lives of Dr. Sheets' clients, free her to practice from anywhere in the world, and become something larger than any single practice?
The session was framed around three goals that have to be true at the same time. Most product decisions that serve only one of them are the wrong decision.
Before imagining the team, it's worth naming the real one. These are the people defining early-life and nutritional microbiome science right now — the intellectual context Lumbiota is entering, and in one case, an asset already in Dr. Sheets' own history.
| Who | Why they matter to Lumbiota |
|---|---|
| Rob Knight (UC San Diego) | Founding director of the Center for Microbiome Innovation; cofounder of the Earth Microbiome & American Gut Projects. Dr. Sheets trained in the Knight Lab — a direct line to the field's most cited figure. |
| Maria Gloria Dominguez-Bello (Rutgers) | Defined how the infant microbiome is founded at birth (mode of delivery, seeding). The science under the "First 1,000 Days" timeline. |
| Martin Blaser (Rutgers) | Missing Microbes — early-life antibiotics and lifelong consequences. The "why act early" argument. |
| Justin & Erica Sonnenburg (Stanford) | Fiber and fermented-food diversity work — the evidence directly under Lumbiota's recipe engine. |
| Meghan Azad (Manitoba / CHILD cohort) | Breast-milk and infant microbiome; the leading early-life longitudinal cohort — a model for the data ambition in §4. |
| Eran Elinav & Eran Segal (Weizmann) | Personalized nutrition, and authors of the probiotics-after-antibiotics study Dr. Sheets already cites on her blog. |
| Tim Spector (King's College / ZOE) | Living proof that sequencing-driven personalized nutrition scales to a consumer app — the closest analog to where Lumbiota is headed. |
| Emeran Mayer (UCLA) | The Mind-Gut Connection — the credible scientific bridge to the mind-body layer discussed in §3 and Bet C. |
A real scientific advisory board would court a subset of these names. Even one — and the Knight connection is the natural first ask — reframes Lumbiota from "wellness app" to "science-backed platform" in an investor's or clinician's eyes.
The standing design-and-product core, plus the new voice. As with the original framework, these are lenses — deliberate points of view assigned to each seat, not quotations from the real people.
Each maps to one of the three goals — and they stack: the second is only possible because of the first, the third only because of the second.
The app absorbs the daily-touch work so clients get value between sessions. Dr. Sheets shifts from delivering plans to reviewing sequencing data and adjusting protocols remotely — a job done from a laptop in Lisbon or a kitchen table, with video check-ins replacing the physical office. Her caseload stops being capped by her calendar, and her location stops being a constraint on her income. This is the "live anywhere with her daughter" unlock, and it's the nearest-term of the three.
First, license her methodology to practitioners she trains and certifies — midwives, doulas, integrative nutritionists — each running their own caseload on her protocols (specified in the Practitioner Console section of the spec). That alone multiplies her reach and creates recurring revenue she never personally bills.
Then the deeper play: every consented, de-identified protocol-and-outcome pair across that network becomes a growing evidence base that makes the protocols better for everyone. This is the Earth Microbiome Project idea — Dr. Sheets' own lineage — pointed at a practical, family-facing goal. The network doesn't just deliver her science; it generates new science. That is what could genuinely move the whole sector, not just her practice.
The reason most protocols fail isn't bad science — it's that stressed, sleep-deprived new parents can't sustain them. A light layer around the evening meal — a breath before cooking, a moment of calm, ritual instead of pressure — does two things at once: it supports the gut-brain axis (real science), and it measurably raises the odds a family actually follows through. This is the one bet that makes the other two work, because a network delivering protocols nobody sticks to produces no outcomes and no data. Keep it evidence-anchored; let it be the emotional texture, not a set of claims.
Not a nutrition app. The trusted operating system for the first 1,000 days — one a mother opens for tonight's dinner, a practitioner runs a global caseload on, and the field itself learns from, one consented family at a time.
Read against the three goals: a mother's life changes because the calm daily companion actually shifts her family's early-life trajectory (Goal 1). Dr. Sheets' life changes because her expertise is untethered from her presence (Goal 2). And the sector changes because a growing, ethically-governed evidence base makes every practitioner on the network better over time (Goal 3). The consumer app isn't the product — it's the on-ramp to all three.